News Results
There are 721,733 News Results
Feb 11, 2025
-- PureHealth achieved a 58% year-on-year increase in revenue to AED 25.8 billion in FY-2024, reflecting a combination of strong organic growth and transformational strategic acquisitions. -- EBITDA grew 69%...
Feb 11, 2025
-- NERLYNX(®) (neratinib) has been approved as a single agent for the treatment of early-stage HER2+ breast cancer, and in combination with capecitabine for the treatment of advanced or metastatic...
Feb 11, 2025
NEW YORK, Feb. 11, 2025 /PRNewswire/ -- Report with market evolution powered by AI - The E-learning market in UK size is estimated to grow by USD 12.66 billion from...
Feb 13, 2025
Prices in Opportunity Zones Targeted for Economic Redevelopment Again Track Broader Changes in U.S. Housing Market; Median Values Rise Quarterly in Half the Zones and Annually in Almost Two-Thirds; Some...
Feb 13, 2025
-- Fabhalta(®) is the first oral monotherapy for previously treated and treatment-naïve adults with paroxysmal nocturnal hemoglobinuria (PNH)(1)(,2) -- Significant unmet need remains in PNH, a chronic, rare and potentially...
Feb 13, 2025
SEATTLE, Feb. 13, 2025 /PRNewswire/ -- Seabourn, the leader in ultra-luxury cruising and expedition travel, is offering an extraordinary line-up of Northern Europe itineraries for the summer 2025 cruise season....
Feb 14, 2025
NEW YORK, Feb. 14, 2025 /PRNewswire/ -- Report with market evolution powered by AI - The global gender reassignment surgery market size is estimated to grow by USD 374.2 million...
Feb 18, 2025
Premium gaming tablet combines powerful performance with brilliant ROG Nebula display in a 13" ultra-compact size FREMONT, Calif., Feb. 18, 2025 /PRNewswire/ -- ASUS Republic of Gamers (ROG) announced that...
Feb 20, 2025
Only One in 14,700 U.S. Homes Sit Vacant During Foreclosure, Near Five-Year Low; Zombie Foreclosures Virtually Unchanged Quarterly, Down 3 Percent Annually; Trends Hold as Overall Foreclosure Activity Remains Down
Feb 24, 2025
-- TAKHZYRO Solution for Injection in 2 mL Pre-Filled Pen is Now Approved to Facilitate Subcutaneous Administration in Adolescent (Aged 12 Years and Above) and Adult Patients with HAE.(1) --...
